What tumors is Larotrectinib suitable for?

Larotrectinib (Larotrectinib) is mainly suitable for TRK (neuronal growth factor receptor) gene fusion-positive tumors. TRKGene fusion is a cancer-related genetic abnormality that can occur in a variety of cancer types. Therefore, the scope of application of larotrectinib covers a variety of cancer types, including but not limited to the following:

1.Children's tumors: Larotrectinib can be used to treat tumors in pediatric patients, including malignant tumors in infancy and childhood, such as congenital fibroblastoma in infants.

2.Breast cancer: Some breast cancer patients may have TRK gene fusions, so larotrectinib may be a treatment option for these specific subtypes of breast cancer.

3.Lung cancer:TRKgene fusion exists in some patients with non-small cell lung cancer (NSCLC), so larotrectinib can also be used in these patients.

4.Kidney cancer: Some patients with kidney cancer may have TRK gene fusions.

5.Colorectal cancer:TRKgene fusions can also be found in colorectal cancer.

6.Thyroid cancer: A small percentage of thyroid cancer patients may have TRK gene fusions.

It should be emphasized that larotrectinib is only effective for TRK gene fusion-positive tumors.在考虑使用拉罗替尼之前，患者通常需要接受基因检测，以确定是否存在TRK基因融合。 Treatment plans should be developed by a professional medical team based on the patient's specific circumstances and condition to ensure the best possible outcome.

Patients and doctors should discuss treatment options, including larotrectinib, together to determine whether it is the most appropriate treatment. This drug may provide significant benefit in certain types of tumors but may not work for all cancer patients. Therefore, it is important to ensure genetic testing is performed to determine the appropriateness of treatment.

Larotrectinib has been launched in China, but it has not been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in China. Please consult the local hospital pharmacy for details. There are original drugs and generic drugs of larotrectinib abroad. The original drugs include German version, American version, European version and Hong Kong version. The price is basically around 20,000 yuan. Generic drugs include Lao and Bangladeshi versions, with prices ranging from two to three thousand. The ingredients of original drugs and generic drugs are basically the same.